IDEXX Labs shares jump as pet diagnostics firm beats Q3 estimates By Investing.com
Update: 2025-11-03
Description
IDEXX Laboratories' Q3 earnings surpassed expectations, with a 13% revenue increase and adjusted earnings of $3.22 per share. The company's Companion Animal Group, led by its VetLab consumable products, drove growth. IDEXX's innovative diagnostic tools and services are gaining traction, boosting demand in the pet healthcare industry. Investors and analysts eagerly await the company's continued performance and future growth prospects.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments 
In Channel




